Sanguine Biosciences Inc., a Valencia, CA-based biotechnology startup, raised a seed funding of undisclosed amount.
Led by Brian Neman, CEO, Sanguine BioSciences is a biotechnology company that aims to provide transparency throughout the personalized medicine R&D process. It collects and de-identifies patient-derived data in the form of biospecimen and physician and self-reported information. These data are generated and then made available to researchers involved in drug and biomarker research and discovery.
The company intends to use the capital to further develop their internal infrastructure in order to efficiently collect, process, document, and store up to 1,000 blood samples each month across the west coast.